Mitochondrial mutations and metabolic adaptation in pancreatic cancer

BACKGROUND: Pancreatic cancer has a five-year survival rate of ~8%, with characteristic molecular heterogeneity and restricted treatment options. Targeting metabolism has emerged as a potentially effective therapeutic strategy for cancers such as pancreatic cancer, which are driven by genetic altera...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Metab
Main Authors: Hardie, Rae-Anne, van Dam, Ellen, Cowley, Mark, Han, Ting-Li, Balaban, Seher, Pajic, Marina, Pinese, Mark, Iconomou, Mary, Shearer, Robert F., McKenna, Jessie, Miller, David, Waddell, Nicola, Pearson, John V., Grimmond, Sean M., Sazanov, Leonid, Biankin, Andrew V., Villas-Boas, Silas, Hoy, Andrew J., Turner, Nigel, Saunders, Darren N.
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2017
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5282905/
https://ncbi.nlm.nih.gov/pubmed/28163917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40170-017-0164-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares